Company Profile

BRHMS LLC works in the areana of Antibody Based Therapeutics - specifically prophylactic countermeasures for encephalitis associated viruses. The firm's approach is to utilize a combination of genome analysis and computational biology to obtain the desired structure of the small molecule agent. It is suggested that there is currenty a capability gap in effective treatments of emerging infectious agents - a gap that could pose significant risk to humans and animals. Many of these agents can lead to encephalitis - a clinical manifestation that can be means prolonged incapacitation or even death. Identifying correct association of therapeutic agents to targets on pathogens is important to increase efficacy of interventional strategies.